查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1716361

2032 年经直肠超音波市场预测：按产品、技术、应用、最终用户和地区分類的全球分析

Transrectal Ultrasound Market Forecasts to 2032 - Global Analysis By Product (Systems and Transducers), Technology (2D Ultrasound, 3D/4D Ultrasound, Doppler Ultrasound and Contrast-Enhanced Ultrasound (CEUS)), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球经直肠超音波市场预计在 2025 年达到 2.639 亿美元，到 2032 年将达到 4.021 亿美元，预测期内的复合年增长率为 6.2%。

经直肠超音波（TRUS）是一种主要用于检查前列腺的医学影像方式。将一个小型超音波探头插入直肠并利用声波创建详细的图像。 TRUS 有助于诊断前列腺疾病、进行切片检查以及评估增大或肿瘤等异常情况。 TRUS 是一种安全、微创的方法，广泛用于诊断前列腺癌等泌尿系统疾病。

根据美国癌症协会发布的数据，预计到2024年底，美国约有288,300名男性被诊断出罹患摄护腺癌。

摄护腺癌盛行率不断上升

推动经直肠超音波(TRUS) 产业发展的主要因素之一是全球前列腺癌盛行率的不断上升。 TRUS 对于诊断前列腺癌至关重要，因为它可以准确定位和早期发现病变。随着即时弹性成像和 MRI-US 融合切片检查等新成像技术使诊断更加准确，需求也在增加。随着新兴国家医疗保健基础设施的改善和政府对前列腺癌研究的资助，市场也不断扩大。综合起来，这些因素使得 TRUS 成为对抗摄护腺癌发生率上升的重要工具。

替代影像方式的可用性

多参数磁振造影 (mpMRI) 等替代成像模式的可用性正在限制 TRUS 市场。多参数 MRI (mpMRI) 通常是首选方案，因为它可以提高前列腺病变的可见性并减少临床上不重要的肿瘤的检测。此外，mpMRI 与标靶切片检查技术结合使用时，与传统的 TRUS 引导切片检查相比，已证明具有更高的诊断准确性。由于这些尖端成像技术的使用日益增多，TRUS 的潜在扩展受到限制，尤其是在医疗保健系统已经成熟的地区。

与标靶切片检查技术的整合

将 TRUS 与 MRI-US 融合切片检查等标靶切片检查技术相结合，可提供巨大的成长机会。透过促进即时成像和对令人担忧的病变的精确定位，这种组合提高了前列腺癌检测的准确性。此外，微超音波技术的改进将实现更高解析度的成像，进一步改善诊断结果。这些发展正在推动从传统诊断技术向更复杂技术的转变，开启新的市场可能性。

成本和报销问题

先进的 TRUS 系统的高成本和严格的报销指南威胁着市场扩张。此类设备的成本仍然是许多地区（尤其是较贫穷的国家）医护人员面临的问题。此外，严格的监管要求和因安全问题而导致的产品召回可能会阻碍市场扩张。

COVID-19的影响：

COVID-19 疫情导致医疗服务中断，对经直肠超音波市场产生了负面影响。由于严格的社交隔离措施和医院就诊次数的减少，前列腺癌的诊断程序减少。疫情导致的需求下降也是由于人们担心超音波技术可能会传播感染。但随着医疗机构的恢復和安全措施的改善，预计该行业将在疫情后恢復势头并呈现稳步发展。

预计预测期内医院部门将实现最大幅度成长。

由于医院基础设施完善且拥有大量合格人员，预计在预测期内医院部门将占据最大的市场占有率。随着前列腺相关疾病的盛行率不断上升，患者选择在医院进行诊断和治疗。此外，医院经常可以使用尖端成像技术，包括 MRI 融合功能和具有即时弹性成像的高解析度 TRUS 系统。公立医院和私立医院都能满足不同病患的需求，确保其在这一细分市场中的主导地位。

预计预测期内 3D/4D超音波领域将以最高的复合年增长率成长。

预计 3D/4D超音波领域将在预测期内见证最高的成长率。这是由于成像能力的提高，可以精确观察前列腺结构。这些最先进的仪器提供品质和准确度更高的即时影像，有助于更好地诊断。与重点切片检查技术相结合，临床结果进一步改善。先进的影像技术和对前列腺癌诊断新方法日益增长的需求是这一市场爆炸式增长的主要驱动力。

比最大的地区

在预测期内，北美预计将占据最大的市场占有率，因为它拥有完善的医疗保健系统和较高的前列腺癌发病率。该地区已拨出大量资金用于研究和开发倡议，以加强诊断技术。强劲的市场需求也是有吸引力的报销规定和对早期检测的高度认识的结果。产业巨头确保医院和诊断机构能够使用尖端的 TRUS 系统，这也推动了该地区的成长。

复合年增长率最高的地区：

预计亚太地区在预测期内的复合年增长率最高。这是由于中国等国家对前列腺疾病早期诊断的认识不断提高以及医疗保健支出不断增加。随着与老龄化相关的前列腺疾病变得越来越普遍，该地区老年人口将会增加，从而增加对 TRUS 设备的需求。此外，鼓励采用医疗技术和改善医疗保健基础设施的政府计划正在帮助推动整个亚太地区的市场扩张。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 初级研究资讯来源
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球经直肠超音波市场（按产品）

  • 系统
    • 基于购物车的系统
    • 可携式/手持式系统
  • 感应器

6. 全球经直肠超音波市场（按技术）

  • 二维超音波
  • 3D/4D超音波
  • 多普勒超音波
  • 造影超音波（CEUS）

7. 全球经直肠超音波市场（依应用）

  • 摄护腺癌
  • 良性摄护腺增生（BPH）
  • 男性不孕症诊断
  • 其他用途

8. 全球经直肠超音波市场（依最终用户）

  • 医院
  • 诊断影像中心
  • 泌尿系统诊所
  • 门诊手术中心（ASC）
  • 学术和研究机构

9. 全球经直肠超音波市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Echo-Son SA
  • Esaote SpA
  • Exact Imaging
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • KOELIS
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Sonablate Corp
  • The Prometheus Group
  • EDAP TMS SA
  • Strata Imaging
  • HALO Medical Technologies
  • Telemed Medical Systems
  • BK Medical
  • Bracco Imaging SpA
Product Code: SMRC29172

According to Stratistics MRC, the Global Transrectal Ultrasound Market is accounted for $263.9 million in 2025 and is expected to reach $402.1 million by 2032, growing at a CAGR of 6.2% during the forecast period. Transrectal ultrasound (TRUS), a medical imaging method, primarily examines the prostate gland. A tiny ultrasound probe is inserted into the rectum to create detailed images using sound waves. TRUS helps diagnose prostate disorders, direct biopsies, and assess anomalies like enlargement or tumors. It is a widely used, safe, and minimally invasive method for identifying urological conditions, including prostate cancer.

According to data published by the American Cancer Society, approximately 288,300 men in the U.S. were estimated to be diagnosed with prostate cancer by the end of 2024

Market Dynamics:

Driver:

Increasing prevalence of prostate cancer

One major factor propelling the transrectal ultrasound (TRUS) industry is the increasing incidence of prostate cancer worldwide. Because TRUS allows for precise lesion localization and early identification, it is essential in the diagnosis of prostate cancer. Demand has also gone up because new imaging technologies, like real-time elastography and MRI-US fusion biopsies, have made diagnosis more accurate. The market is also growing as a result of enhanced healthcare infrastructure in emerging nations and government financing for prostate cancer research. When taken as a whole, these elements make TRUS a vital instrument for combating the rising incidence of prostate cancer.

Restraint:

Availability of alternative imaging techniques

The availability of substitute imaging modalities, such as multiparametric MRI (mpMRI), constrains the TRUS market. Multiparametric MRI (mpMRI) is often the preferred option due to its enhanced visibility of prostate lesions and its ability to reduce the detection of tumors that are not clinically significant. Also, when used with targeted biopsy methods, mpMRI has been found to be more accurate in diagnosing compared to regular TRUS-guided biopsies. TRUS's potential for expansion is constrained by the growing use of these cutting-edge imaging techniques, particularly in areas with established healthcare systems.

Opportunity:

Integration with targeted biopsy techniques

Combining TRUS with targeted biopsy methods like MRI-US fusion biopsies presents a significant opportunity for growth. By facilitating real-time imaging and accurate targeting of worrisome lesions, this combination improves the detection accuracy of prostate cancer. Furthermore, improvements in micro-ultrasound technology provide imaging with higher resolution, which enhances diagnostic results even more. These developments are propelling a change from traditional diagnostic techniques to more sophisticated ones, opening up new market potential prospects.

Threat:

Cost and reimbursement issues

The high expenses of sophisticated TRUS systems and restrictive reimbursement guidelines threaten the market's expansion. The cost of these gadgets continues to be a problem for healthcare practitioners in many areas, especially in poor nations. Furthermore, strict regulatory requirements and product recalls triggered by safety concerns may hinder market expansion.

Covid-19 Impact:

The COVID-19 epidemic negatively impacted the transrectal ultrasound market by causing disruptions in healthcare services. Prostate cancer diagnostic procedures decreased as a result of strict social distancing measures and fewer hospital visits. The pandemic's drop in demand was also due to worries about ultrasound technology spreading infections. Nonetheless, the industry is anticipated to regain momentum and show steady development in the post-pandemic phase as healthcare institutions recover and implement improved safety measures.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment is expected to account for the largest market share during the forecast period because of their sophisticated infrastructure and abundance of qualified personnel. Patients choose hospital-based diagnoses and treatments due to the rising incidence of prostate-related illnesses. Additionally, hospitals frequently have access to state-of-the-art imaging technologies such as MRI fusion capabilities or high-resolution TRUS systems with real-time elastography. Both public and private hospitals, catering to various patient demands, guarantee their dominant position in this market segment.

The 3D/4D ultrasound segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the 3D/4D ultrasound segment is predicted to witness the highest growth rate. This is due to its enhanced imaging capabilities, which enable accurate observation of prostate architecture. These cutting-edge devices provide real-time images with improved quality and accuracy, facilitating better diagnosis. Their combination with focused biopsy procedures further enhances clinical results. The development of imaging technology and the increasing need for novel approaches to prostate cancer diagnostics are the main drivers of this market's explosive expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of its established healthcare system and high incidence of prostate cancer. Considerable funds are allocated to research and development initiatives to enhance diagnostic technologies in the region. Strong market demand is also a result of attractive reimbursement regulations and high awareness of early-stage disease identification. Major industry companies guarantee access to cutting-edge TRUS systems in hospitals and diagnostic facilities, which is fueling the growth in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This is due to the increasing awareness of early prostate disease diagnosis and the rising healthcare costs in countries such as China and India. As age-related prostate disorders become more common, the region's growing geriatric population base increases demand for TRUS equipment. Furthermore, government programs encouraging the adoption of medical technology and improvements to healthcare infrastructure are driving market expansion throughout Asia Pacific.

Key players in the market

Some of the key players in Transrectal Ultrasound Market include Echo-Son SA, Esaote SpA, Exact Imaging, Fujifilm Holdings Corporation, GE Healthcare, KOELIS, Koninklijke Philips N.V., Siemens Healthineers AG, Sonablate Corp, The Prometheus Group, EDAP TMS SA, Strata Imaging, HALO Medical Technologies, Telemed Medical Systems, BK Medical, and Bracco Imaging S.p.A.

Key Developments:

In November 2024, EDAP TMS SA announced positive clinical results regarding its robotic High-Intensity Focused Ultrasound (HIFU) treatment for deep infiltrating endometriosis at the 2024 AAGL Global Congress. A study presented by Professor Gil Dubernard compared the outcomes of HIFU therapy to traditional surgical methods, revealing that patients undergoing HIFU experienced significantly reduced moderate and severe postoperative complications, shorter hospital stays, and improved overall health. The study analyzed data from 120 patients and found that HIFU could serve as a less invasive alternative to surgery, addressing a condition with limited treatment options. The company is working on further evaluations and plans to discuss these findings with the FDA as it advances its Phase 3 trial for HIFU treatment.

In September 2024, Koelis, SAS, a global leader and innovator in prostate care, announced the release of a new, compact 3D transducer for transperineal fusion biopsy and treatment. Koelis is now compatible with both the market leading high-level disinfection systems (Trophon(R) and Astra(R)VR).

In March 2024, GE HealthCare (Nasdaq: GEHC) announced the launch of Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature. As a global leader in ultrasound-guided solutions in urology, this AI-based software feature is designed to support clinicians in prostate imaging, biopsies and guiding treatment. This new feature assists urologists by offering a solution that improves workflow and quickly captures prostate volume. The added functionality with PVA can determine calculations and measurements of the organ with an automated, one-click process.

Product Covered:

  • Systems
  • Transducers

Technologies Covered:

  • 2D Ultrasound
  • 3D/4D Ultrasound
  • Doppler Ultrasound
  • Contrast-Enhanced Ultrasound (CEUS)

Applications Covered:

  • Prostate Cancer
  • Benign Prostatic Hyperplasia (BPH)
  • Male Infertility Diagnosis
  • Other Applications

End Users Covered:

  • Hospitals
  • Diagnostic Imaging Centers
  • Urology Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Academic & Research Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transrectal Ultrasound Market, By Product

  • 5.1 Introduction
  • 5.2 Systems
    • 5.2.1 Cart-Based Systems
    • 5.2.2 Portable/Handheld Systems
  • 5.3 Transducers

6 Global Transrectal Ultrasound Market, By Technology

  • 6.1 Introduction
  • 6.2 2D Ultrasound
  • 6.3 3D/4D Ultrasound
  • 6.4 Doppler Ultrasound
  • 6.5 Contrast-Enhanced Ultrasound (CEUS)

7 Global Transrectal Ultrasound Market, By Application

  • 7.1 Introduction
  • 7.2 Prostate Cancer
  • 7.3 Benign Prostatic Hyperplasia (BPH)
  • 7.4 Male Infertility Diagnosis
  • 7.5 Other Applications

8 Global Transrectal Ultrasound Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Diagnostic Imaging Centers
  • 8.4 Urology Clinics
  • 8.5 Ambulatory Surgical Centers (ASCs)
  • 8.6 Academic & Research Institutes

9 Global Transrectal Ultrasound Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Echo-Son SA
  • 11.2 Esaote SpA
  • 11.3 Exact Imaging
  • 11.4 Fujifilm Holdings Corporation
  • 11.5 GE Healthcare
  • 11.6 KOELIS
  • 11.7 Koninklijke Philips N.V.
  • 11.8 Siemens Healthineers AG
  • 11.9 Sonablate Corp
  • 11.10 The Prometheus Group
  • 11.11 EDAP TMS SA
  • 11.12 Strata Imaging
  • 11.13 HALO Medical Technologies
  • 11.14 Telemed Medical Systems
  • 11.15 BK Medical
  • 11.16 Bracco Imaging S.p.A.

List of Tables

  • Table 1 Global Transrectal Ultrasound Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Transrectal Ultrasound Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Transrectal Ultrasound Market Outlook, By Systems (2024-2032) ($MN)
  • Table 4 Global Transrectal Ultrasound Market Outlook, By Cart-Based Systems (2024-2032) ($MN)
  • Table 5 Global Transrectal Ultrasound Market Outlook, By Portable/Handheld Systems (2024-2032) ($MN)
  • Table 6 Global Transrectal Ultrasound Market Outlook, By Transducers (2024-2032) ($MN)
  • Table 7 Global Transrectal Ultrasound Market Outlook, By Technology (2024-2032) ($MN)
  • Table 8 Global Transrectal Ultrasound Market Outlook, By 2D Ultrasound (2024-2032) ($MN)
  • Table 9 Global Transrectal Ultrasound Market Outlook, By 3D/4D Ultrasound (2024-2032) ($MN)
  • Table 10 Global Transrectal Ultrasound Market Outlook, By Doppler Ultrasound (2024-2032) ($MN)
  • Table 11 Global Transrectal Ultrasound Market Outlook, By Contrast-Enhanced Ultrasound (CEUS) (2024-2032) ($MN)
  • Table 12 Global Transrectal Ultrasound Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global Transrectal Ultrasound Market Outlook, By Prostate Cancer (2024-2032) ($MN)
  • Table 14 Global Transrectal Ultrasound Market Outlook, By Benign Prostatic Hyperplasia (BPH) (2024-2032) ($MN)
  • Table 15 Global Transrectal Ultrasound Market Outlook, By Male Infertility Diagnosis (2024-2032) ($MN)
  • Table 16 Global Transrectal Ultrasound Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 17 Global Transrectal Ultrasound Market Outlook, By End User (2024-2032) ($MN)
  • Table 18 Global Transrectal Ultrasound Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 19 Global Transrectal Ultrasound Market Outlook, By Diagnostic Imaging Centers (2024-2032) ($MN)
  • Table 20 Global Transrectal Ultrasound Market Outlook, By Urology Clinics (2024-2032) ($MN)
  • Table 21 Global Transrectal Ultrasound Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 22 Global Transrectal Ultrasound Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.